Tag Archives: Ulcerative

Xeljanz Recommended Dosage For Ulcerative Colitis Patients May Increase Risk Of Pulmonary Embolism

FDA Is Reviewing Safety Of Xeljanz 10 mg Twice-Daily Dose Of This JAK In­hibitor, According to February 2019 News Reports   (Posted by Tom Lamb at DrugInjuryWatch.com)   Pfizer's Xeljanz (tofacitinib) is approved by the FDA for treatment of adult … Continue reading

Posted in Injury & Accident Law | Tagged , , , , , , , , , | Leave a comment